Literature DB >> 22688758

Working safely with vaccinia virus: laboratory technique and review of published cases of accidental laboratory infections.

Stuart N Isaacs1.   

Abstract

Vaccinia virus (VACV), the prototype orthopoxvirus, is widely used in the laboratory as a model system to study various aspects of viral biology and virus-host interactions, as a protein expression system, as a vaccine vector, and as an oncolytic agent. The ubiquitous use of VACVs in the laboratory raises certain safety concerns because the virus can be a pathogen in individuals with immunological and dermatological abnormalities, and on occasion can cause serious problems in normal hosts. This chapter reviews standard operating procedures when working with VACV and reviews published cases on accidental laboratory infections.

Entities:  

Mesh:

Year:  2012        PMID: 22688758     DOI: 10.1007/978-1-61779-876-4_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Both CD8+ and CD4+ T Cells Contribute to Corneal Clouding and Viral Clearance following Vaccinia Virus Infection in C57BL/6 Mice.

Authors:  I V Larsen; H Clausius; A W Kolb; C R Brandt
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

2.  Seroprevalence of Orthopoxvirus in rural Brazil: insights into anti-OPV immunity status and its implications for emergent zoonotic OPV.

Authors:  Galileu Barbosa Costa; Lídia Teodoro Santos Augusto; Juliana Almeida Leite; Paulo César Peregrino Ferreira; Cláudio Antônio Bonjardim; Jônatas Santos Abrahão; Erna Geessien Kroon; Elizabeth Castro Moreno; Giliane de Souza Trindade
Journal:  Virol J       Date:  2016-07-04       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.